Equities

Aarti Drugs Ltd

AARTIDRUGS:NSI

Aarti Drugs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)524.90
  • Today's Change4.90 / 0.94%
  • Shares traded78.62k
  • 1 Year change-8.90%
  • Beta1.0738
Data delayed at least 15 minutes, as of Sep 20 2024 11:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue25,28627,16124,886
OPERATING EXPENSES
Cost of revenue total19,97022,01419,674
Selling, general and admin. expenses, total1,9321,9141,770
Depreciation/amortization514503500
Unusual expense(income)----0
Other operating expenses, total919173
Total operating expense22,59024,56922,061
Operating income2,6962,5912,825
Other, net(34)(34)46
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes2,3552,2422,700
Provision for income taxes639578650
Net income after taxes1,7161,6642,050
Minority interest(1.73)(0.48)0.43
Net income before extra. Items1,7141,6632,050
Total extraordinary items------
Net income1,7141,6632,050
Inc.avail. to common excl. extra. Items1,7141,6632,050
Inc.avail. to common incl. extra. Items1,7141,6632,050
EPS RECONCILIATION
Basic/primary weighted average shares929393
Basic/primary eps excl. extra items191822
Basic/primary eps incl. extra items191822
Dilution adjustment------
Diluted weighted average shares929393
Diluted eps excl. extra items191822
Diluted eps incl. extra items191822
COMMON STOCK DIVIDENDS
DPS - common stock primary issue--1.001.00
Gross dividend - common stock9293--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental330322195
SUPPLEMENTAL INCOME
Depreciation, supplemental510503500
Total special items1.83--0
NORMALISED INCOME
Normalized income before taxes2,3572,2422,700
Effect of special items on income taxes0.50--0
Income tax excluding impact of special items640578650
Normalized income after tax1,7171,6642,050
Normalized income avail. to common1,7161,6632,050
Basic normalized EPS191822
Diluted normalized EPS191822
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.